Biotest AG | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
47,800.00
46,900.00
34,800.00
24,000.00
26,000.00
6,000
Depreciation, Depletion & Amortization
31,800.00
32,500.00
22,000.00
19,900.00
22,300.00
24,600
Other Funds
-
-
-
1,800.00
1,100.00
14,700
Funds from Operations
77,800.00
67,100.00
29,400.00
48,200.00
46,600.00
33,300
Changes in Working Capital
84,800.00
77,300.00
9,300.00
18,500.00
12,000.00
79,500
Net Operating Cash Flow
7,000.00
10,200.00
38,700.00
66,700.00
34,600.00
46,200
Capital Expenditures
42,900.00
44,700.00
94,000.00
133,200.00
106,500.00
Sale of Fixed Assets & Businesses
10,400.00
800.00
100.00
-
200.00
Purchase/Sale of Investments
-
59,700.00
60,100.00
110,600.00
10,000.00
Net Investing Cash Flow
32,500.00
103,600.00
160,700.00
34,800.00
148,300.00
Cash Dividends Paid - Total
6,200.00
7,900.00
8,300.00
1,200.00
2,400.00
Issuance/Reduction of Debt, Net
119,400.00
95,300.00
3,700.00
1,300.00
58,700.00
Net Financing Cash Flow
186,900.00
87,400.00
4,600.00
1,700.00
55,200.00
Net Change in Cash
147,200.00
25,000.00
125,600.00
31,000.00
58,700.00
Free Cash Flow
47,100.00
54,900.00
55,300.00
66,500.00
71,900.00
Change in Capital Stock
73,700.00
-
-
-
-
Exchange Rate Effect
200.00
1,400.00
1,000.00
800.00
200.00
Other Uses
-
-
6,700.00
12,200.00
52,000.00
About Biotest
View Profile
